AdvisorShares Psychedelics ETF (PSIL)
| Assets | $5.91M |
| NAV | $2.62 |
| Expense Ratio | 0.68% |
| PE Ratio | n/a |
| Shares Out | 2.26M |
| Dividend (ttm) | $0.05 |
| Dividend Yield | 1.88% |
| Ex-Dividend Date | Sep 26, 2022 |
| 1-Year Return | -69.36% |
| Volume | 19,012 |
| Open | 2.89 |
| Previous Close | 2.75 |
| Day's Range | 2.85 - 3.00 |
| 52-Week Low | 2.50 |
| 52-Week High | 10.70 |
| Beta | 1.41 |
| Holdings | 33 |
| Inception Date | Sep 15, 2021 |
About PSIL
The fund is an actively managed ETF that seeks to achieve its investment objective by investing, under normal circumstances, at least 80% of its net assets (plus any borrowings for investment purposes) in securities of companies that derive at least 50% of their net revenue from or devote 50% of their assets to psychedelic drugs and derivatives that have economic characteristics similar to such securities. The fund primarily invests in publicly listed life sciences companies focused on psychedelic medicines as well as other companies with activities in the psychedelics business. The fund is non-diversified.
Top 10 Holdings
66.94% of assets| Name | Symbol | Weight |
|---|---|---|
| COMPASS Pathways | CMPS | 11.76% |
| Cybin Inc Ordinary Shares | CYBN.NE | 8.94% |
| ATAI Life Sciences | ATAI | 8.01% |
| Blackrock Treasury Trust Instl 62 | n/a | 6.88% |
| Seelos Therapeutics | SEEL | 6.51% |
| Relmada Therapeutics | RLMD | 5.37% |
| Sage Therapeutics | SAGE | 4.99% |
| FSD Pharma Inc Ordinary Shares - Class B (Sub Voting) | HUGE.CN | 4.91% |
| GH Research | GHRS | 4.84% |
| Intra-Cellular Therapies | ITCI | 4.73% |
News
Best-Performing ETFs of August Up At Least 15%
These ETFs gained at least 15% in the downbeat month of August.
5 Top-Performing Sector ETFs of August
The month of August was marked by ups and downs.
7 Psychedelics Stocks to Buy for a Big Drug Boom
Psychedelics stocks are becoming increasingly mainstream, in part due to changing social attitudes. Psychedelic drugs “are a loosely grouped class of drugs that are able to induce altered thoughts and s...